BC
RLAY icon

BIT Capital’s Relay Therapeutics RLAY Stock Holding History

BIT Capital’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-284,508
Closed -$1.17M – 139
2024
Q4 		$1.17M Buy
+284,508
New +$1.55M 0.09% 66
2024
Q2 		– Sell
-152,439
Closed -$1.27M – 124
2024
Q1 		$1.27M Buy
+152,439
New +$1.49M 0.09% 81
2023
Q2 		– Sell
-58,761
Closed -$968K – 167
2023
Q1 		$968K Buy
58,761
+20,044
+52% +$359K 0.14% 65
2022
Q4 		$578K Buy
38,717
+14,289
+58% +$274K 0.12% 64
2022
Q3 		$546K Buy
24,428
+19,938
+444% +$437K 0.1% 62
2022
Q2 		$75.2K Sell
4,490
-10
-0.2% -$214 0.01% 101
2022
Q1 		$135K Buy
+4,500
New +$109K 0.01% 100

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

BIT Capital's RLAY Position: Q1 2025 in Review

BIT Capital sold out of Relay Therapeutics (RLAY) in Q1 2025, closing a stake of 284,508 shares — an estimated $1.17M sold.

BIT Capital first reported a position in RLAY in Q1 2022 and held it in 7 quarters. The position peaked at $1.27M in Q1 2024. 207 funds tracked by Wall St. Rank hold RLAY as of Q1 2025.

  • BIT Capital reported no remaining Relay Therapeutics position as of Q1 2025 after selling out during the quarter.
  • BIT Capital sold 284,508 Relay Therapeutics shares in Q1 2025, an estimated $1.17M.
  • BIT Capital first reported a position in Relay Therapeutics in Q1 2022 and held it in 7 quarters.
  • BIT Capital's Relay Therapeutics position peaked at $1.27M in Q1 2024.
  • 207 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2025.

Based on BIT Capital's 13F filing for Q1 2025, filed 9 May 2025.